Clinical Trial Update: Study in Human iPSCs-derived RPE Cells Transplantation for Late-Stage AMD [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial sponsored by The First Affiliated Hospital with Nanjing Medical University is evaluating transplantation of iPSC-derived retinal pigm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• iPSC-derived RPE cell transplantation (induced pluripotent stem cell-derived retinal pigment epithelium cells)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: AMD - Age-Related Macular Degeneration | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING